-

Pearl’s Second Opinion Recognized with 2022 Cellerant Best of Class Technology Award

Second Opinion®, the only patient-facing, FDA-cleared AI radiologic aid for detecting numerous dental diseases, has been selected as one of the top innovations in dentistry

LOS ANGELES--(BUSINESS WIRE)--Pearl, the leader in dental AI solutions, announced today that Second Opinion®, its chairside artificial intelligence (AI) software to help dentists detect numerous conditions in x-rays of dental patients, has been selected as a 2022 Best of Class Technology Award recipient by Cellerant Consulting Group. Technology and innovations that are recognized must have “revolutionized, simplified, or advanced their category in a distinctive way,” according to Cellerant Consulting. A panel of industry leaders including Paul Feuerstein, DMD, John Flucke, DDS, Marty Jablow, DMD, Pam Maragliano-Muniz, DMD, Chris Salierno, DDS, and Lou Shuman, DMD deliberate and choose the recipients of the awards.

Pearl has established itself at the forefront of the dental AI revolution with a suite of computer vision solutions aimed at elevating the standard of dental care by improving precision and consistency. Second Opinion® applies computer vision AI technology to identify key pathologic and nonpathologic conditions in dental radiographs, including dental caries (cavities), bone loss, periapical radiolucencies (root abscesses), calculus (tartar), and faulty restorations. It is the only dental AI software cleared by the United States Food and Drug Administration (FDA) to detect multiple forms of disease, as well as the only such software cleared for radiologic evaluation of adolescent and teenage patients.

“At Pearl, our goal is to bring dentistry’s most advanced clinical artificial intelligence systems to practices around the world and fundamentally advance dental diagnosis, treatment, clinical performance and practice management,” said Ophir Tanz, founder and CEO of Pearl. “AI-informed decision-making will elevate the standard of care and help to ensure optimal patient health outcomes. We are honored to have been recognized by such a distinguished panel of thought leaders and educators.”

Second Opinion® is the only dental AI software with multi-national regulatory clearances including in the U.S., European Union, Canada, Australia, New Zealand, United Arab Emirates, Saudi Arabia and Brazil. To learn more about this year’s Cellerant Best of Class Technology Awards, visit the Dental Products Report website here.

About Pearl

Pearl is shaping the future of dental care by delivering AI and computer vision solutions that advance efficiency, accuracy, transparency and patient care. Founded in 2019 by Ophir Tanz, Pearl is backed by Craft Ventures and other leading venture capital firms. For more information or to request a demonstration, please visit https://www.hellopearl.com.

Contacts

Alex Foley
Matter Health for Pearl
Pearl@matternow.com

Pearl


Release Versions

Contacts

Alex Foley
Matter Health for Pearl
Pearl@matternow.com

More News From Pearl

Pearl Names Eugene Katz Senior Vice President of Customer Success to Advance Provider-First Dental AI

LOS ANGELES--(BUSINESS WIRE)--Pearl, the global leader in dental AI solutions, today announced the appointment of Eugene Katz as Senior Vice President of Customer Success. In this newly created role, Katz will lead Pearl’s customer success organization, building on the company’s established provider-first approach to deepen adoption and ensure dental teams continue to realize meaningful value from Pearl’s AI in everyday practice. Katz brings more than a decade of experience leading customer suc...

Coast Dental Chooses Pearl to Power AI-Driven Care Across 88 Locations

LOS ANGELES--(BUSINESS WIRE)--Coast Dental, a patient-centric dental support organization serving nearly one million patients annually, has selected Pearl, the global leader in dental AI solutions, as its exclusive dental AI partner, deploying Pearl’s technology across its network of 88 practices. By choosing Pearl, Coast Dental is embedding AI as a foundational layer of intelligence across its clinical and operational environment. Rather than deploying AI as a standalone point solution limited...

Pearl Expands Dental AI Capabilities with FDA Clearance for Panoramic X-Rays

LOS ANGELES--(BUSINESS WIRE)--Pearl, the global leader in AI solutions for dentistry, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for AI-powered detection of dental pathologies on panoramic radiographs. This latest clearance expands Pearl’s clinically validated radiologic AI technology to the most widely captured extraoral imaging modality in dentistry, and is now available to Second Opinion® users in the U.S. and internationally. This clearance...
Back to Newsroom